John Ketchum has more than 30 years of experience in the biomedical space, including more than 20 years at Novartis. During this time, he was a member of the Novartis Oncology Executive Committee and European Pharma organization Board Level International Committee, and held roles spanning pre-launch commercialization, clinical development, product launch and marketing, and general management on six continents.

Currently John is a senior business advisor to pharmaceutical and biotech companies from R&D-stage through commercialization and patent expiry. In addition, he serves as a mentor to early-stage biotechs through local mentoring programs. John also serves as an advisor and the Chairman of the Board of Ernest Pharmaceuticals LLC, a privately held oncology company.

John received a Bachelor of Arts degree from Hamilton College and an MBA from the University of North Carolina at Chapel Hill.